|
High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease
RECRUITINGN/ASponsored by Anhui Medical University
Actively Recruiting
PhaseN/A
SponsorAnhui Medical University
Started2020-06-01
Est. completion2025-12-01
Eligibility
Age50 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04599764
Summary
To investigate the clinical effect neural mechanism of high-definition transcranial direct current stimulation combined with cognitive training on early AD
Eligibility
Age: 50 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria: * Subject diagnosed with early Alzheimer's disease or related diseases according to NINCDS-ACDRADA criteria. * Subjects must have a MMSE score between 10 and 27,indicating mild cognitive impairment or dementia * CDR score ≤ 2 * Subject under treatment by IAChE for at least 3 months. * psychotropic treatments are tolerated if they were administered and unchanged for at least 3 months Exclusion Criteria: * CDR \> 2 * Any history or clinical signs of other severe psychiatric illnesses (like major depression,psychosis or obsessive compulsive disorder). * History of head injury,stroke,or other neurologic disease. * Organic brain defects on T1 or T2 images. * History of seizures or unexplained loss of consciousness. * Implanted pacemaker,medication pump,vagal stimulator,deep brain stimulator. * Family history of medication refractory epilepsy. * History of substance abuse within the last 6 months.
Conditions4
Alzheimer's DiseaseEarly Alzheimer's DiseaseFunctional Magnetic Resonance ImagingTranscranial Direct Current Stimulation
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorAnhui Medical University
Started2020-06-01
Est. completion2025-12-01
Eligibility
Age50 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04599764